ConductScience.org, home

Paper26608331

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.

Marty C and 11 others. Blood, 2016. Cited by 229 papers, by iCite.

Cite this record

ConductScience Library. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Papers, record 26608331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26608331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
PubMed
Journal
Blood
PubMed
Year
2016
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
229
iCite
Relative citation ratio, by iCite
7.07
iCite
Revised in PubMed
2024-03-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marty CCaroline
2Pecquet CChristian
3Nivarthi HHarini
4El-Khoury MMira
5Chachoua IIlyas
6Tulliez MMicheline
7Villeval JLJean-Luc
8Raslova HHana
9Kralovics RRobert
10Constantinescu SNStefan N
11Plo IIsabelle
12Vainchenker WWilliam

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalreticulinMajor topic
INDEL MutationMajor topic
MegakaryocytesMajor topic
Primary MyelofibrosisMajor topic
Receptors, ThrombopoietinMajor topic
ThrombocytosisMajor topic
Animals
Frameshift Mutation
Janus Kinase 2
Mice
Mice, Mutant Strains

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in26965919Mutant calreticulin: when a chaperone becomes intrusive.https://conductscience.org/library/papers/26965919

Source PubMed

Download CSV of comments and corrections

Cited by156

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.

PMIDTitleJournalYearIn PapersSource
42956057Molecular and functional analysis of calcium binding by a cancer-linked calreticulin mutant.Elife2026https://conductscience.org/library/papers/42956057PubMed
42811375Megakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications.Biomark Res2026https://conductscience.org/library/papers/42811375PubMed
42806053PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications.Leukemia2026https://conductscience.org/library/papers/42806053PubMed
42786200Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling.Leukemia2026https://conductscience.org/library/papers/42786200PubMed
42745000Type 1 interferon perturbates clonal competition by reshaping human blood development.Nat Genet2026https://conductscience.org/library/papers/42745000PubMed
42689321Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease.Arterioscler Thromb Vasc Biol2026https://conductscience.org/library/papers/42689321PubMed
42613432Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.Leukemia2026https://conductscience.org/library/papers/42613432PubMed
42346284Frequency of Non-Type I/II CALR Mutations in Patients Undergoing Molecular Diagnostics for Myeloproliferative Neoplasms.Diseases2026https://conductscience.org/library/papers/42346284PubMed
42131291CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment.Hemasphere2026https://conductscience.org/library/papers/42131291PubMed
41971416Plasma cfDNA and peripheral blood gDNA provide complementary information for molecular monitoring in myeloproliferative neoplasms.Front Oncol2026https://conductscience.org/library/papers/41971416PubMed
41959476Targeting TPO/MPL Signaling to Mitigate JAK2V617F-driven Cardiac Microvascular Disease.bioRxiv2026https://conductscience.org/library/papers/41959476PubMed
41798678Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasms.Blood Neoplasia2026https://conductscience.org/library/papers/41798678PubMed
41532194A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo.Am J Hematol2026https://conductscience.org/library/papers/41532194PubMed
41268701Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41268701PubMed
40857671Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis.Blood2026https://conductscience.org/library/papers/40857671PubMed
40623967JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.Nat Commun2025https://conductscience.org/library/papers/40623967PubMed
40619749JCMM Annual Review on Advances in Biotechnology for the Treatment of Haematological Malignancies: A Review of the Latest In-Patient Developments 2024-2025.J Cell Mol Med2025https://conductscience.org/library/papers/40619749PubMed
40586641CALR Type 1-Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation.Cell Biol Int2025https://conductscience.org/library/papers/40586641PubMed
40403318Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.Blood2025https://conductscience.org/library/papers/40403318PubMed
40355863Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm.Cell Commun Signal2025https://conductscience.org/library/papers/40355863PubMed

See all 156 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26608331

GET https://conductscience.org/api/papers/v1/26608331/cited_by?page=2